New Brunswick, NJ, United States of America

Prakash V Parab

This inventor holds 18 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Astrazeneca Ab, Skinmedica, Inc.. Active years: 1992-2015.

USPTO Granted Patents = 18

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 1.6

ph-index = 8

Forward Citations = 312(Granted Patents)

Location History:

Williamsville, NY (US) (1992 - 2000)
Plainsboro, NJ (US) (2002)
Monroe Township, NJ (US) (2005 - 2008)
New Brunswick, NJ (US) (2010 - 2015)

Company Filing History:

16 out of 3,737

Bristol-Myers Squibb Compnay

Years Active: 1992-2015

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9198925 - Pharmaceutical formulations containing an SGLT2 inhibitor (2015-12-01),

2. 8716251 - Pharmaceutical formulations containing an SGLT2 inhibitor (2014-05-06),

3. 8361972 - Pharmaceutical formulations containing an SGLT2 inhibitor (2013-01-29),

4. 8221786 - Pharmaceutical formulations containing an SGLT2 inhibitor (2012-07-17),

5. 7851502 - Pharmaceutical formulations containing an SGLT2 inhibitor (2010-12-14),

6. 7374770 - Topical composition for follicular delivery of an ornithine decarboxylase inhibitor (2008-05-20),

7. 6977257 - Aripiprazole oral solution (2005-12-20),

8. 6353029 - Storage stable tretinoin and 4-hydroxyanisole containing topical composition (2002-03-05),

9. 6019988 - Methods and compositions for enhancing skin permeation of drugs using (2000-02-01),

10. 5885596 - Methods and compositions for fine lines and/or wrinkles (1999-03-23),

11. 5807600 - Reduction of cutaneous atrophy (1998-09-15),

12. 5705168 - Enhanced permeation of alpha-hydroxy acid enantiomer (1998-01-06),

13. 5702711 - Method for enhancing the rate of skin permeation of lactic acid through (1997-12-30),

14. 5527802 - New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) (1996-06-18),

15. 5420106 - Method and composition having enhanced alpha-hydroxy acid skin (1995-05-30),

Title: Innovative Inventor Spotlight: Prakash V Parab

Introduction:

Prakash V Parab, a prolific inventor based in New Brunswick, NJ, has made significant contributions to the field of pharmaceutical formulations. With an impressive portfolio of 18 patents, Parab's groundbreaking work has sparked interest and innovation in the industry.

Latest Patents:

Parab's latest patents focus on pharmaceutical formulations containing an SGLT2 inhibitor. These formulations, presented in the form of capsules or tablets for oral use, consist of dapagliflozin or its propylene glycol hydrate along with a pharmaceutical acceptable carrier. Designed for immediate release, these formulations showcase Parab's expertise in developing advanced pharmaceutical solutions.

Career Highlights:

Throughout his career, Parab has garnered experience and expertise working with renowned companies such as Bristol-Myers Squibb Company and AstraZeneca. His tenure at these organizations has undoubtedly influenced his innovative approach to drug development and formulation.

Collaborations:

Collaboration plays a key role in innovation, and Parab has had the opportunity to work alongside notable colleagues in the field. Some of his coworkers include Dilbir S Bindra and Mandar V Dali, who have contributed to the success of their collective projects through shared expertise and dedication.

Conclusion:

In conclusion, Prakash V Parab stands out as a visionary inventor in the pharmaceutical industry, with a remarkable track record of patents and collaborations. His work continues to drive advancements in drug formulation and pave the way for future innovations in healthcare.